Monashee Investment Management LLC Celldex Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$35.22 - $51.88 $447,610 - $659,342
-12,709 Reduced 12.68%
87,500 $3.67 Million
Q4 2023

Feb 12, 2024
BUY
$22.61 - $40.65 $2.27 Million - $4.07 Million
100,209 New
100,209 $3.97 Million
Q3 2020

Nov 13, 2020
SELL
$9.65 - $15.19 $2.9 Million - $4.56 Million
-300,000 Closed
0 $0
Q2 2020

Aug 11, 2020
BUY
$1.61 - $13.41 $483,000 - $4.02 Million
300,000 New
300,000 $3.9 Million

Others Institutions Holding CLDX

# of Institutions
207
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.26B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email